These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7060044)

  • 1. Third-line chemotherapy with mitomycin, vinblastine, and carmustine (BCNU) in refractory breast carcinoma: a pilot study.
    Veronesi A; Tirelli U; Galligioni E; Trovò MG; Crivellari D; Donatella Magri M; Roncadin M; Tumolo S; Grigoletto E
    Cancer Treat Rep; 1982 Mar; 66(3):559-61. PubMed ID: 7060044
    [No Abstract]   [Full Text] [Related]  

  • 2. Phase II study of mitomycin C and vinblastine in women with advanced breast cancer refractory to standard cytotoxic therapy.
    Denefrio JM; East DR; Troner MB; Vogel CL
    Cancer Treat Rep; 1978 Dec; 62(12):2113-5. PubMed ID: 751719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Alternative treatment with carmustine, vindesine and tamoxifen in previously cytostaticly (VAC, FMC) treated patients with metastatic breast cancer].
    Massner B; Voss I; Queisser W; Drings P; Fritze D; Westerhausen M
    Onkologie; 1982 Aug; 5 Suppl():46-51. PubMed ID: 6752791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasibility study of combining metronidazole with chemotherapy.
    Stewart DJ; Maroun JA; Young V; Crook AF; Hopkins HS; Yan RC; Richard MT; Hugenholtz H; Bélanger R; Heringer R
    J Clin Oncol; 1983 Jan; 1(1):17-23. PubMed ID: 6422002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Acute dyspnea following intravenous administration of vinblastine/mitomycin C].
    Lagler U; Gattiker HH
    Schweiz Med Wochenschr; 1989 Mar; 119(9):290-2. PubMed ID: 2496465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination chemotherapy with BCNU, vincristine, mitomycin-C and prednisone in refractory breast carcinoma. A pilot study.
    DiBella NJ; Garfield D; Fink K; Anderson P; Speer J; Murphy J
    Oncology; 1984; 41(1):1-3. PubMed ID: 6422372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MVP (mitomycin, vinblastine, and progesterone): a second-line regimen in ovarian cancer with a high incidence of pulmonary toxicity.
    Ozols RF; Hogan WM; Ostchega Y; Young RC
    Cancer Treat Rep; 1983; 67(7-8):721-2. PubMed ID: 6871888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Navelbine: a new step in cancer therapy?
    Armand JP; Marty M
    Semin Oncol; 1989 Apr; 16(2 Suppl 4):41-5. PubMed ID: 2652319
    [No Abstract]   [Full Text] [Related]  

  • 9. [Chemotherapy associating mitomycin C, thiotepa and vindesine in advanced breast cancers. Study of 100 cases (author's transl)].
    Chauvergne J; Durand M; Brunet R; Bui BN; Hoerni B; Mauriac L
    Bull Cancer; 1981; 68(5):442-8. PubMed ID: 6800426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of KW-2083 in Stage D adenocarcinoma of the prostate].
    Yoshimoto J; Ochi J; Nasu Y; Obama T; Tsushima T; Matsumura Y; Ohmori H
    Gan To Kagaku Ryoho; 1985 May; 12(5):1156-7. PubMed ID: 3994400
    [No Abstract]   [Full Text] [Related]  

  • 11. Mitomycin C and vinblastine chemotherapy for advanced breast cancer.
    Konits PH; Aisner J; van Echo DA; Lichtenfeld K; Wiernik PH
    Cancer; 1981 Sep; 48(6):1295-8. PubMed ID: 6791808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vinorelbine and cisplatin (CIVIC regimen) for the treatment of metastatic breast carcinoma after failure of anthracycline- and/or paclitaxel-containing regimens.
    Ray-Coquard I; Biron P; Bachelot T; Guastalla JP; Catimel G; Merrouche Y; Droz JP; Chauvin F; Blay JY
    Cancer; 1998 Jan; 82(1):134-40. PubMed ID: 9428489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Second and third line chemotherapy in advanced breast cancer.
    Alexopoulos A; Rigatos G; Stavrinidis E; Stavrakakis J; Scartsilas C; Papacharalambous A
    J Chemother; 1989 Jul; 1(4 Suppl):1189-90. PubMed ID: 16312828
    [No Abstract]   [Full Text] [Related]  

  • 14. Combination chemotherapy for bronchogenic carcinoma with doxorubicin, BCNU, and cyclophosphamide (ABC): a pilot study of the Southeastern Cancer Study Group.
    Denes AE; Presant CA; Bartolucci A
    Cancer Treat Rep; 1982 Jan; 66(1):199-200. PubMed ID: 7053258
    [No Abstract]   [Full Text] [Related]  

  • 15. Mitomycin-C and vinblastine in advanced breast cancer.
    Navarro M; Bellmunt J; Balañá C; Colomer R; Jolis L; del Campo JM
    Oncology; 1989; 46(3):137-42. PubMed ID: 2497417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pilot study of vinorelbine (Navelbine) and paclitaxel (Taxol) in patients with refractory breast cancer and lung cancer.
    Chang AY; Garrow GC
    Semin Oncol; 1995 Apr; 22(2 Suppl 5):66-70; discussion 70-1. PubMed ID: 7740336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Combined chemotherapy of bronchial carcinomas (author's transl)].
    Karrer K; Pridun N; Denck H
    Z Erkr Atmungsorgane; 1980; 155(1):21-40. PubMed ID: 6259843
    [No Abstract]   [Full Text] [Related]  

  • 18. [Chemotherapy of carcinoma of the breast].
    Periti P; Mazzei T
    Minerva Ginecol; 1982 Nov; 34(11):959-62. PubMed ID: 7155423
    [No Abstract]   [Full Text] [Related]  

  • 19. Multimodal treatment of advanced breast cancer.
    Spanos WJ; Montague ED; Hortobagyi GN; Schell S
    Prog Clin Cancer; 1982; 8():237-43. PubMed ID: 6818613
    [No Abstract]   [Full Text] [Related]  

  • 20. Solid tumor chemotherapy: new drugs and horizons.
    Yardumian H
    J Am Osteopath Assoc; 1974 Dec; 74(4):299-306. PubMed ID: 4140203
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.